About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, December 17th, 2013

The QualityStocks
Daily Stock List

graphic
graphic

DMH International, Inc. (DMHI)

PennyStocks24, PremiereStockAlerts, MyBestStockAlerts, Stock Shock and Awe, Fast Money Alerts, Penny Stock General, Penny Picks, Damn Good Penny Picks, and Penny Stock Newsletter reported on DMH International, Inc. (DMHI), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

DMH International, Inc., through their subsidiary, Touch Medical Solutions, Inc. is a medical software and device company. The Company specializes in PACS (Picture Archiving and Communications Systems), EHR (Electronic Hospital Records), EMR (Electronic Medical Records), PHR (Personal Health Records), Medical Transcription, and Paperless Medical Office Solutions. DMH International has their headquarters in Coral Springs, Florida.

The Company’s TouchPACS/TouchEMR Software Suite (TMS) is a software product that consists of PACS – a Picture Archive and Control System application. PACS is the current standard for displaying diagnostic quality medical images electronically. TMS also consists of EMR – an Electronic Medical Records application, which is part of a new and evolving standard for the capture, storage, and dissemination of patient medical information, and the integration of the healthcare environment.

Furthermore, TMS consists of Practice Management. TMS contains all functionality needed to run the business of a radiology practice, or any small to medium medical practice regardless of specialty. These functions include system security, scheduling and appointment management, workflow, mailing list and patient contact management, customer accounting, billing and collection, insurance company billing, interface to external vendors, and other functions required in medical offices.

Last week, DMH International provided an update concerning their proposed acquisition of Virtual Physician's Network (VPN). On October 21, 2013, DMH announced that they had signed a definitive Letter of Intent (LOI) to acquire 100 percent of VPN, a medical software and applications provider. On October 30, 2013, DMH announced that VPN President, Mr. George England, had agreed to become the CEO of the company upon completion of the merger.

On November 13, 2013, DMH International announced that Mr. William McCullough and his development team will take over the future software development of DMH; this includes Touch Medical Solutions and VPN. The acquisition required definitive agreements to be created along with audited financials to be provided by VPN. The expectation is that this will be completed by the end of January 2014.

DMH International, Inc. (DMHI), closed Tuesday's trading session at $0.019, down 15.56%, on 245,000 volume with 26 trades. The average volume for the last 60 days is 98,505 and the stock's 52-week low/high is $0.0025/$0.25.

Inergetics, Inc. (NRTI)

The Stock Scout, PennyStockClub, Penny Stock Pros, PennyStockPlayers, and FeedBlitz reported earlier on Inergetics, Inc. (NRTI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Inergetics, Inc. is a top developer of patented nutritional products consisting of high-quality ingredients and proprietary formulations. The Company has targeted brands that independently serve the the Clinical Nutrition, Long Term Care (Senior Care), and Sports Nutrition Markets. Their brand portfolio features Martha Stewart Essentials™, which is a complete line of whole-food based supplements created specifically for women. Inergetics is based in Newark, New Jersey.

In addition, the Company’s brands include Surgex® Sports Nutrition, which is the preferred nutritional supplement of Army Sports. Since 2011, Surgex continues to supply the sports teams of the Army Black Knights. Inergetics’ Surgex® Sports Nutrition is a clinically studied performance enhancing formula. The design of it is to build lean muscle and increase energy to obtain top levels of power and stamina. It is designed to increase peak power, improve endurance, and accelerate recovery time so athletes can consistently train harder and compete at their pinnacle. Surgex® Sports Nutrition features innovative formulas developed to meet the nutritional needs of the masses and professional and amateur athletes.

Additionally, Inergetics’ brands include Bikini Ready®. Bikini Ready® is their complete line of weight loss lifestyle products. Bikini Ready® products include Weight Loss Catalyst, Fashion Multi, Cleanse, as well as Yummy Shake Flavors, all specially designed for women.

Inergetics’ also offers SlimTrim™, an affordable, premium value diet brand The design of SlimTrim™ is to help one lose weight, burn fat, stimulate metabolism, cleanse and curb appetite. The formulation of SlimTrim™ is to work with an individual's body naturally in combination with exercise and diet.

In early December, Inergetics and The Podiatree Company announced that they launched Intrinsix — the only podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D. The Podiatree Company is a leader in podiatry pharmaceuticals.

Intrinsix contains a unique pharmacist-formulated blend of alpha lipoic acid, benfotiamine, calcium, and vitamins B6, B12 and D. The formula is safe for patients with strict dietary restrictions. This includes vegetarians and those with sugar-free, sodium-free and starch-free diets. Intrinsix has been distributed for sale to local podiatrists across the United States. It will be available immediately to their patients.

Inergetics, Inc. (NRTI), closed Tuesday's trading session at $0.1098, down 3.60%, on 444,654 volume with 29 trades. The average volume for the last 60 days is 122,975 and the stock's 52-week low/high is $0.0406/$0.21.

International Isotopes, Inc. (INIS)

SmallCapVoice reported previously on International Isotopes, Inc. (INIS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Idaho Falls, Idaho-based International Isotopes, Inc. manufactures a full spectrum of nuclear medicine calibration and reference standards, high purity fluoride gases, and an array of cobalt-60 products such as teletherapy sources. In addition, the Company provides a wide choice of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. International Isotopes also provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

The International Isotopes business consists of five major business segments. These include the Depleted Uranium De-Conversion and Fluorine Extraction Process (FEP) Project; Radiochemicals for Cancer Treatment; Nuclear Medicine Reference and Calibration Standards; Medical Teletherapy Products, and Transportation Services.

The Company has developed a unique process to convert depleted uranium tails (the by-product produced from the enrichment of uranium) to ultra-high purity, high value industrial fluoride products. Fluoride products are a crucial raw material for microelectronics, fiber optic cable, thin film photovoltaics (solar cells) and many other manufacturing processes.

International Isotopes exclusively owns the patents for the fluorine extraction process. The Company’s de-conversion process will convert the DUF6 by-product (or tails) from uranium enrichment operations into depleted uranium tetrafluoride (DUF4). International Isotopes will subsequently use their patented FEP technology to extract fluorine from the DUF4 for use in the manufacture of specialty, high-value fluoride gases.

The Company is working to advance their planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility in Lea County, approximately 15 miles west of Hobbs, New Mexico. The new facility will be on a 640-acre site. The Company believes this new commercial facility will provide an excellent commercial opportunity. International Isotopes holds patents that give them exclusive rights for the Fluorine Extraction Process (FEP). This process produces high value, high purity fluoride gasses in tandem with uranium de-conversion.

In October 2012, International Isotopes announced that they received a license from the U.S. Nuclear Regulatory Commission (NRC) to build a depleted uranium de-conversion and fluorine extraction processing facility. The license, which has a 40-year term, was signed October 2, 2012 by the NRC. The plant will use a two-step process to extract fluorine from depleted uranium. This is for use in solar materials, microelectronics, and the petrochemical markets. The Company has their first de-conversion Service Agreement already in place with URENCO USA. URENCO is the leader in U.S. commercial enrichment.

International Isotopes, Inc. (INIS), closed Tuesday's trading session at $0.065, up 18.18%, on 405,279 volume with 34 trades. The average volume for the last 60 days is 684,911 and the stock's 52-week low/high is $0.0225/$0.195.

HII Technologies, Inc. (HIIT)

Secret Stock Club, Stocks Gone Wild, PennyStockClub, The Stock Scout, Penny Stock Pros, PennyStocks24, and Penny Stock Rumble reported earlier on HII Technologies, Inc. (HIIT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, HII Technologies, Inc. is an oilfield services company with operations in Texas, Oklahoma, Ohio, and West Virginia. The Company is positioned to leverage the major anticipated growth in horizontal drilling and hydraulic fracturing within the United States' active shale and unconventional "tight oil" plays. This is through deploying oilfield related technologies to enhance the value of services the Company offers their customers. HII Technologies has their headquarters in Houston, Texas.

Their frac water supply and flow back services subsidiary does business as AES Water Solutions and AquaTex. AES provides services in transporting high volumes of water by way of 10 inch aluminum pipe from the source to the drill site.  The piping is mobile and can be quickly installed at any location. The Company’s onsite oilfield contract safety consultancy does business as AES Safety Services. AES Safety Services was established to develop and assist Oilfield E & P companies with their Health, Safety and Environmental programs.

HII Technologies’ mobile oilfield power subsidiary does business as South Texas Power (STP). STP was formed to provide the oilfield a complete solution for their temporary power and specialized equipment needs. This subsidiary’s equipment ranges from custom 20kW to 300kW diesel units, with larger custom sizes.

HII Technologies centers on providing products and service-based solutions to their oilfield customers to increase their returns and minimize down time and problems. Their management team has considerable experience in portable power and water transfer hydro-fracing markets. The Company’s field operations are chiefly in Texas and Oklahoma.

In November, HII Technologies announced that they acquired Aqua Handling of Texas, LLC. This is an oilfield frac water transfer service company located in the Eagle Ford Shale area of South Texas that operates under the above-mentioned name "AquaTex". AquaTex engages in the business of high volume water transfer services through above-ground mobile piping solutions with environmentally safe, no-leak systems designed to support the millions of gallons normally required for hydraulic fracturing in hydrocarbon reservoirs. AquaTex has contracts with nationally recognized exploration & production companies in the Eagle Ford Shale and South Texas regions.

HII Technologies, Inc. (HIIT), closed Tuesday's trading session at $0.61, down 1.61%, on 37,200 volume with 22 trades. The average volume for the last 60 days is 55,198 and the stock's 52-week low/high is $0.07/$0.62.

FONU2, Inc. (FONU)

PennyStocks24, OTCJournal, Stock Exploder, Blaque Capital Stocks, Email Stock Picks, PennyStock PayCheck, JackpotStock Picks, RagingStock Bull, PennyStock MarketBulls, and Xtreme Stock Picks reported on FONU2, Inc. (FONU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FONU2, Inc. is a social commerce company that lists on the OTC Markets’ OTCQB. The Company provides a precision mobile sales and marketing platform, which functions like an order reservations and booking system. Members, through their mobile phones and computers, list, buy, sell, and trade services and items locally in any neighborhood, anywhere globally. The payment of transactions are with the FONU2 end-to-end mobile phone payment card system.

Founded in 2009, FONU2 is based in Oakland Park, Florida. The Company previously went by the name Cygnus Internet, Inc. They changed their name to FONU2, Inc. in April of 2012.

The FONU2 App combines social commerce and social networking. The FONU2 app merges extreme social media management, aggressive viral campaigns, News Feed, Localization and Notification interaction. This allows FONU2 Facebook members to connect with customers around the world. Members will have control to multiple "public marketing page" profiles and will be able to sell, trade or buy products and services. The precision of FONU2's Facebook Platform enables smooth social commerce experiences across many electronic devices.

In addition, FONU2 involves in gamification. The Company offers a varied and growing Game section. This allows their members to interact through an assortment of venues online. Gamification allows FONU2 to engage deeper with their audience, partners and consumers, while offering them the ability to share, collaborate and participate with Facebook friends, family members and online communities.

Earlier this month, FONU2 announced that their social commerce platform and affiliate marketing opportunities are attracting record numbers of interested parties. Within the past four months, the FONU2 website has experienced a considerable increase in visitor traffic and interest from beta-testers and potential affiliate marketers.

Today, FONU2 announced that the Company is employing multiple layers of security to ensure their users are safe, regardless of the platform they use when accessing FONU2. The Company is ensuring a secure environment for their customers through following best practices from The Open Web Application Security Project (OWASP), IBM, CISCO, Amazon Web Services (AWS), Rapid7, and Microsoft.

FONU2, Inc. (FONU), closed Tuesday's trading session at $0.05, down 8.42%, on 709,800 volume with 46 trades. The average volume for the last 60 days is 105,726 and the stock's 52-week low/high is $0.017/$0.42.

Sanwire Corp. (SNWR)

PennyStocks24, Pumps and Dumps, Penny Stocks Finder, Penny Stock Craze, Beacon Equity Research, SuperStockTips, Stock Preacher, and InvestorSoup reported this month on Sanwire Corp. (SNWR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Based in Tulsa, Oklahoma, Sanwire Corp. is a global provider of wireless communications services, data solutions, and application software/hardware. The Company’s vertically integrated portfolio of solutions target a diverse collection of enterprises and multiple disciplines. Sanwire focuses on the development and acquisition of first-rate wireless communications companies and technologies. The Company’s shares trade on the OTC Markets’ OTCQB.

Sanwire has two wholly owned subsidiaries, iPTerra Technologies and Aero Networks. iPTerra is a designer, developer, manufacturer and marketer of a real-time two-way wireless and/or wireline communications, and mine-safety solution for the international mining and industrial industry. iPMine is iPTerra’s flagship solution. It allows mine operators to communicate (voice, text, and video), track, locate, identify, and monitor with every miner and piece of equipment in a mine - from an office computer desktop, or from anywhere globally with an internet connection.

The Aero Networks subsidiary provides advanced telecommunications and broadband services to rural communities and Native American tribes with a focus on the public safety, education, and healthcare sectors. Aero is a pioneer in delivering 4G/LTE, TV White Space, and advanced wireless technologies. Aero offers consulting services, broadband services, and operations support.

In October, Sanwire announced that Aero Networks signed a Letter of Intent (LOI) with the Fort Peck Tribes of Montana to provide a full complement of broadband infrastructure and communication services to tribal residents and surrounding businesses. The LOI sets out the principal terms and conditions to which Aero and Fort Peck are willing to enter into an exclusive telecommunications development and supporting contracts definitive agreement for the installation and construction of fiber optic, cable systems networks with various OSP support structures, direct burial and ISP structured cable systems, and various building support structure installations.

In early December, Sanwire announced the appointment of Mr. Rick Bjorklund as the Company's new Chairman of the Board and Director. At present, Mr. Bjorklund is the President of Sanwire's wholly owned subsidiary Aero Networks. The appointment was effective immediately. Mr. Bjorklund has been instrumental in growing Aero Networks’ revenues. He will continue to implement their growth strategies along with Sanwire's expansion plans. Mr. Bjorklund will continue to manage Aero's operations as their President.

Sanwire Corp. (SNWR), closed Tuesday's trading session at $0.065, up 8.33%, on 390,050 volume with 30 trades. The average volume for the last 60 days is 51,633 and the stock's 52-week low/high is $0.04/$1.00.

First Power and Light, Inc. (VOLT)

SmallCapVoice and internetnews reported previously on First Power and Light, Inc. (VOLT), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A solar EPC firm, First Power and Light, Inc. is a premier solar photovoltaic system installer based in Bridgeport, Pennsylvania. The Company provides energy solutions to customers nationwide and to date, they have completed more than 400 Federal Government, commercial and residential solar panel installations. In addition, First Power and Light has offices in Arizona, California, New Jersey, Maryland, New York, Virginia, Washington DC, and Florida.

The Company’s mission is to provide affordable solar energy solutions to their customers, perform a valuable community service, and provide these benefits in a sustainable, long-term manner.  First Power and Light provides a fully-integrated service - from initial consultation, system design, and installation, to maintenance and management of the custom system. The Company has announced the use of a “hybrid” solar thermal panel, allowing their customers to decrease heat and electric bills.

First Power and Light recently announced that the Company’s acquisition target, First Power and Light, LLC (FPL) signed an Engineering, Procurement and Construction (EPC) contract valued at $7.5 million to install a 2-megawatt solar array on an existing landfill, which will supply electricity to the community of Gilbertsville, Pennsylvania. The system to be installed will use approximately 8,000 panels - 250 kW panels. The project's developers will use approximately 15 acres of land. They selected FPL to be the EPC contractor.  The projection is that FPL will break ground on this project by the first of the year.

Last month, First Power and Light announced that FPL signed a Letter of Intent (LOI) to acquire SolPower Renewables, Inc. (a Florida corporation) in a stock only transaction. FPL is in the wholesale, liquidation and solar panel procurement business; one of their divisions is a prominent EPC firm building residential and commercial solar arrays.

SolPower sells Engineering, Procurement and Construction (EPC) services in Florida, South and Central America, and the Caribbean. FPL intends for SolPower to operate as a wholly owned subsidiary allowing them to maintain their focus on these geographic areas not currently serviced by FPL. First Power and Light is in the process of completing their acquisition of FPL. Company Management will finalize this acquisition upon completion of FPL's audit. The audit of FPL is presently continuing.

First Power and Light, Inc. (VOLT), closed Tuesday's trading session at $0.0807, down 10.33%, on 57,800 volume with 6 trades. The average volume for the last 60 days is 131,270 and the stock's 52-week low/high is $0.04/$2.47.

Cytta Corp. (CYCA)

Real Pennies, Greenbackers, AddictivePennyStocks, PennyStockRumors.net, and Actual Gains reported previously on Cytta Corp. (CYCA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cytta Corp. involves in the development and installation of a remote medical monitoring model to deliver medical data transmission from home to the insurer. The Company’s Cytta Connect™ is a Remote Data Capture system connecting Bluetooth devices to online Electronic Biometric Records (EBR). Cytta Connect™ is the world’s first open source Healthcare Special Purpose Cellular and Satellite Network™. Founded in 2006, OTCQB-listed Cytta has their headquarters in Las Vegas, Nevada.

Cytta’s open source EBR is for use by patients, doctors, caregivers, health insurers (Professional Care) with the Company’s reprogrammed Cytta smartphones, and any wellness or fitness user (Consumer) with any Cellular Carrier's smartphone.  The Cytta Connect™ automatic and cloud based medical data repository can be customized to fit with a user’s health requirements via the use of the Cytta Health Engine™. The Cytta Health Engine™ is used to display patient data in various formats. Using the Cytta Health Engine™, the data can be displayed in different numerical formats, can be graphed to show trends of these measurements and the unstructured data may be analysed to provide early warning signs of dangerous health trends. 

Cytta’s system collects the data generated by the home based medical monitoring devices, such as blood pressure, scale, blood glucose, and pulse oxygen through employing Bluetooth connectivity. This medical data is sent via Bluetooth from the medical device to Cytta’s Medical Smartphone, which is also located in the home and/or held by the patient.

Cytta Connect™ is a mobile and WIFI platform for collecting verifiable and objective data for anyone needing medical monitoring. This includes insurers, payors health plans, managed care organizations, health delivery organizations, medical groups, IPAs, ACO’s, hospitals, and individuals.

Yesterday, Cytta's Chief Executive Officer, Mr. Gary Campbell announced major strides in Satellite and Platform Network Connectivity. In an open letter to all shareholders, he stated, “Our targeted healthcare solution is Cytta's signature development and affords government, healthcare providers, caregivers and patients' full control and access to their remotely generated health and wellness data. This system of unlocked connectivity will soon expand beyond our earthly cellular and WIFI mobile capability to include Satellite capability everywhere.”

Cytta Corp. (CYCA), closed Tuesday's trading session at $0.1649, even for the day. The average volume for the last 60 days is 12,508 and the stock's 52-week low/high is $0.01/$0.4848.

graphic

The QualityStocks
Company Corner

graphic
graphic

Big Tree Group, Inc. (BIGG)

The QualityStocks Daily Newsletter would like to spotlight Big Tree Group, Inc. (BIGG). Today, Big Tree Group, Inc. closed trading at $0.238, up 2.59%, on 351,896 volume with 62 trades. The stock’s average daily volume over the past 60 days is 58,429, and its 52-week low/high is $0.055/$2.99.

Big Tree Group, Inc. announced today its plans to open a toy sales and distribution center in Thailand in order to expand its sales presence in the Southeast Asia market and has entered into an agreement with Bumrung Muang Plaza Company Limited for the planned leasing of approximately 4,000 square meters of showroom space in Bangkok, Thailand. Big Tree Group intends to use the showroom as a hub for the expansion of its toy distribution business in the rapidly growing Southeast Asia market.

Big Tree Group, Inc. (BIGG) is an authorized sales agent for thousands of toy manufacturers in China and provides multiple procurement services for international toy distributors and wholesalers. The company is headquartered in Shantou City of Guangdong province, a city known as the toy capital of the world. It’s here that Big Tree operates a 21,000-square-foot-showroom to display its products to thousands of international toy purchasers. The company has an on-site testing laboratory where all toys undergo rigorous testing to ensure both quality and function before reaching the showroom floor.

Big Tree Group serves as a “one-stop-shop” for the international sourcing and distribution of toys and other related products. Big Tree Group currently represents more than 8,000 toy manufacturers offering more than 300,000 varieties of toy products such as remote control toys, digital toys, sports toys, play sets, educational toys, dolls and infant toys. Big Tree conducts operations through both of their subsidiaries, Big Tree Brunei and Big Tree Shantou.

The company has developed and patented a proprietary construction toy, the Magic Puzzle (3D). The Big Tree Magic Puzzle has been well received but is currently promoted and distributed in only the Chinese domestic market. Global marketing and distribution of the Magic Puzzle is under evaluation and could create significant channels sales.

China is the world’s leading toy manufacturer and exporter, producing and distributing two-thirds of the multi-billion dollar toy industry’s global demand. The nation’s manufacturing is highly regional, with 70 percent of toy sales in China generated in the Guangdong province. Strategically located in this province, Big Tree has cultivated an extensive customer base in Asia and Europe and is strategically planning global expansion and distribution, especially in the Americas.

Big Tree’s operations are spearheaded by long-time China toy industry veteran CEO Wei Lin, who founded the toy export and import company Shantou Dashu Toy Corp. Ltd. He is supported by an seasoned and experienced management team proficient in operations management, marketing, sales, team management, education and accounting. Big Tree’s management team has established an aggressive growth strategy to expand sales and global product distribution by utilizing their expansive multi-lingual sales team to leverage industry contacts, identify strategic mergers and acquisitions, and maximize trade and industry opportunities. Disclaimer

Big Tree Group, Inc. Company Blog

Big Tree Group, Inc. News:

Big Tree Group to Open Toy Sales and Distribution Center in Thailand to Expand Its Presence in the Southeast Asia Market

Big Tree Group Provides Financial Forecast for 2013 Year End Financial Results and Outlook for 2014

Big Tree Group, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2013

On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.115, even for the day, on 104,766 volume with 21 trades. The stock’s average daily volume over the past 60 days is 196,227, and its 52-week low/high is $0.0027/$0.403.

On the Move Systems, Inc. announced today that it is moving forward with negotiations to put together fantasy sports getaway packages for racing fans before the first date of the TUDOR United SportsCar Championship next month at Daytona International Speedway. OMVS is in talks with the Xperience to potentially develop multi-tiered travel packages for racing fans and sponsors, including opportunities to attend important races, meet the drivers, hang with the pit crew and even take a few laps around the track.

On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.

Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.

Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.

OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters. Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS Works to Ready Racing Getaway Packages for Daytona Debut

OMVS Engineers New Business Travel Solutions as Transportation Costs Rise

OMVS Opens Talks to Double Size of Partner Network

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.003, on 418,111 volume with 4 trades. The stock’s average daily volume over the past 60 days is 2,221,454, and its 52-week low/high is $0.0025/$0.029.

Singlepoint, Inc. announced today that it has entered into a partnership agreement with Prescott-Clearwater Technologies for development and deployment of Singlepoint's exciting new mobile ad serving platform. "We are extremely pleased to be launching what will become a robust revenue generating model utilizing our proprietary SMS advertising technology," states Singlepoint CEO, Greg Lambrecht.

Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.

The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.

Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.

SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

Singlepoint, Inc. Enters Partnership With Prescott-Clearwater Technologies to Launch Mobile Ad Platform

Singlepoint, Inc.'s Acquisition of Six Sigma Leads to Million Dollar Revenue Increase in Q3 2013

Singlepoint, Inc. Announces Moody Bible Institute to White Label Technology for Mobile Donations, SMS Capabilities

Intelimax Media, Inc. (IXMD)

The QualityStocks Daily Newsletter would like to spotlight Intelimax Media, Inc. (IXMD). Today, Intelimax Media, Inc. closed trading at $0.025, up 25.00%, on 41,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 90,855, and its 52-week low/high is $0.0032/$0.39.

Intelimax Media, Inc. (IXMD) is a digital entertainment company specializing in fantasy sports, social gaming, entertainment, and software solutions. Primarily focused on the daily fantasy sports and social gaming sectors, the company is applying its advanced technologies to fully capitalize on the convergence of key trends in the ever-expanding social gaming space.

The company’s team of experts has identified key opportunities in the rapidly emerging daily fantasy sports and social media sectors. Leveraging its proprietary DraftTeam.com platform, the company is generating multiple revenue streams. Innovative plans for international expansion are underway to maximize exposure and traffic through various online and mobile channels.

It's estimated by the Fantasy Sports Trade Association that over 40 million people play some form of a fantasy sport each year in North America. Participation has grown over 30 percent annually the past four years with 19 percent of all males in the U.S. playing fantasy sports. Fantasy sports are estimated to have a $4–$5 billion annual economic impact across the sports industry.

Intelimax Media offers exciting and entertaining online brands that attract a loyal audience and in turn facilitate lucrative revenues from management fees, product placement, and software sales. Backed by personnel with a proven track record in the finance, growth and development of successful companies, the company is poised for rapid growth in the Internet and entertainment sectors.

Intelimax Media also trades on the Canadian market under the symbol (IMD). Disclaimer

Intelimax Media, Inc. Company Blog

Intelimax Media, Inc. News:

Intelimax Announces Adoption of Advance Notice Policy

Intelimax Updates Membership Growth Disclosure

Intelimax launches 2013/14 NHL Hockey on DraftTeam.com

Sohm, Inc. (SHMN)

The QualityStocks Daily Newsletter would like to spotlight Sohm, Inc. (SHMN). Today, Sohm, Inc. closed trading at $0.0038, up 18.75%, on 168,499 volume with 5 trades. The stock’s average daily volume over the past 60 days is 300,646, and its 52-week low/high is $0.0021/$0.013.

Sohm, Inc. (SHMN) is a globally recognized pharmaceutical manufacturer that develops, manufactures, and distributes generic, private label, and Sohm-innovated pharmaceutical, cosmeceutical, and nutraceutical products. The company exports product worldwide, with a focus on distribution in emerging markets such as Africa, Latin America, and Southeast Asia.

In 2012, Sohm was voted the fastest growing generics prescription drug manufacturer at the 30th All India Conference of National Integrated Medical Association. Committed to being a global leader in improving the health and quality of people’s lives in every corner of the world, the company has U.S. headquarters in Buena Park, CA, with international headquarters located in Ahmedabad, India, and several corporate offices located within the UK and China.

Research and development activities capitalize on the company’s expertise in numerous drug delivery technologies, including solid dosage form, oral-controlled and sustained releases semi-solid, liquid, oral transmucosal, transdermal, gel, injectable, and other drug delivery technologies, as well as the application of these technologies to proprietary drug forms.

To ensure regulatory compliance, the company continuously assesses and monitors the output of the existing quality systems, and application of evolving industry guidelines and regulations. Leveraging a global presence, an expanding drug portfolio that covers all major treatment categories, and a respected brand, Sohm is well positioned to continue its rapid growth.. Disclaimer

Sohm, Inc. Company Blog

Sohm, Inc. News:

SOHM Posts FH2013 Financial Results, Provides Full-Year Outlook

SOHM Launches SohMed(TM) Range of Branded OTC Medicines in U.S. Market

SOHM Introduces Second Innovative Skincare Line Product, Salic-2(R) Gel for Acne

Max Sound Corp. (MAXD)

The QualityStocks Daily Newsletter would like to spotlight Max Sound Corp. (MAXD). Today, Max Sound Corp. closed trading at $0.22, up 7.32%, on 442,987 volume with 54 trades. The stock’s average daily volume over the past 60 days is 271,411, and its 52-week low/high is $0.165/$0.394.

Max Sound Corp. (MAXD) is an HD Audio Technology company with proprietary software that significantly improves the sound quality from virtually any digital or analog source - without increasing file size. Leveraging a strategic software licensing business model, MAX-D’s market is vast and includes improving recorded music, movies, audio books, live streaming, televised events, video games, television network programming, and all audio on mobile devices.

Through Max Sound’s recent acquisition of Liquid Spins, MAX-D has aligned its Technology with a significant audience who purchase music through smart devices. Liquid Spins is a digital media distribution company that has contracts with all major record labels in the United States, and specializes in targeted marketing strategies that focus on selling music in areas where music is not currently sold.

Backed by seasoned management, a competitive advantage, and strong intellectual properties, the company’s MAX-D Audio Process is poised to revolutionize the way consumers listen to media and communicate on their mobile devices. The MAX-D Technology restores audio to the highest quality in real time, while maximizing the output potential of virtually any device - without requiring any equipment change or upgrade in infrastructure.

Consumers have become unaware that they are listening to inferior compressed audio – in much the same way that HD television opened our eyes to a better picture quality, MAX-D opens our ears, to a realistic, true to life listening experience. MAX-D™ is Audio Perfected. Disclaimer

Max Sound Corp. Company Blog

Max Sound Corp. News:

Max Sound Corporation to Present at 6th Annual LD MICRO Conference on December 3rd

MAX-DŽ HD Delivers Audio Perfection Experience on SnapdragonŽ DSP

Max Sound Corporation to Present at Singular's 8th Annual Best of the Uncovereds Conference

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.30, up 15.38%, on 500 volume with 1 trades. The stock’s average daily volume over the past 60 days is 5,759, and its 52-week low/high is $0.25/$0.90.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Provides Update on $36 Million Strategic Financing Agreement

VistaGen Therapeutics Presents CardioSafe 3D and LiverSafe 3D Developments at International Society of Stem Cell Research's 11th Annual Meeting

VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue

Boston Therapeutics, Inc. (BTHE)

The QualityStocks Daily Newsletter would like to spotlight Boston Therapeutics, Inc. (BTHE). Today, Boston Therapeutics, Inc. closed trading at $1.49, up 11.19%, on 19,894 volume with 10 trades. The stock’s average daily volume over the past 60 days is 13,221, and its 52-week low/high is $0.15/$1.65.

Boston Therapeutics, Inc. (BTHE) is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs. An IP portfolio solidifies the company's position in the pharmaceutical industry. Boston Therapeutics' current product pipeline, PAZ320 and IPOXYNT, is comprised of therapies developed to treat patient populations with Type 2 diabetes.

PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrate in foods during digestion. Boston Therapeutics believes PAZ320 is a safe and effective drug compound for people with pre-diabetes and diabetes in their daily management of blood glucose levels, fulfilling an unmet medical need. PAZ320 has completed a Phase ll clinical trial at Dartmouth Medical Center. 45% of the patients responded with a 40% reduction in the elevation of post meal blood sugar compared to baseline with no serious adverse events.

IPOXYNT, a universal oxygen carrier, is an injectable Rx for prevention of necrosis and treatment of ischemic conditions which may lead to necrosis. This compound is not a biologic, but a second generation New Chemical Entity HBOC (hemoglobin based oxygen carrier). The potential for this product goes well beyond Lower Limb Ischemia into a range of areas from anemia and blood loss (injury), to cardiovascular disease and surgical blood supplementation.

The Boston Therapeutics management and advisory team has extensive expertise in complex carbohydrate chemistry, regulatory affairs, and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration. Backed by a team with more than five decades of expertise in public and private business management, the company is well positioned to advance its status as a premier developer of complex carbohydrate-based new chemical entities. Disclaimer

Boston Therapeutics, Inc. Company Blog

Boston Therapeutics, Inc. News:

Boston Therapeutics Appoints Three to Management Positions

Boston Therapeutics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Boston Therapeutics Appoints Conroy Chi-Heng Cheng and S. Colin Neill to Board of Directors

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMister
(MDLH)

2.

Stock Analyzer
(OLIE)

3.

Wise Alerts
(NECA)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251